Anticholium Injection
Product Images NDC 81284-831

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Anticholium (NDC 81284-831). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Provepharm Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ampule (Anticholium Ampule)

This is a 5 mL solution for injection of a medication called ANTICHOLIUM*. The solution contains 2 mg of physostigmine salicylate per 5 mL (0.4 mg/mL). It is intended for intravenous use. The manufacturer of this solution is DR. FRANZ KOHLER CHEMIE GMBH, located at Werner-von-Siemens-Str. 14-28, D-64625 Bensheim, Germany. The lot number and expiration date are not available.*

FDA Label Image

Carton (Anticholium Carton)

FDA Label Image

Us Product Label (Dhcp 1)

This is a description for a medication called Physostigmine Salicylate Injection. It is supplied in a 2 mL single dose ampule with a concentration of 1 mg/mL. The medication is intended for either lumbar or lateral ventricular use. The NDC number for this product is 17478-510-02. It is distributed by Akom Reonly, located in Gumee, with the PSADL number L6031. The lot number and expiration date are not readable in the provided text.*

FDA Label Image

Import Product Label (Dhcp 2)

This is a 5 mL solution for injection containing 2 mg of physostigmine salicylate (0.4 mg/mL). It is intended for intravenous use and is manufactured by DR. FRANZ KOHLER CHEMIE GMBH located in Bensheim, Germany. The lot number and expiration date are not available.*

FDA Label Image

List Of Adverse Reactions (Dhcp 3)

This text contains information about the potential side effects or disorders that can occur in different organ systems. However, the text is not readable and contains errors. Therefore, a useful description cannot be generated.*

FDA Label Image

List Of Adverse Reactions (Dhcp 4)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.